Mesenchymal Stem Cells Market Size

Mesenchymal Stem Cells Market Size

Mesenchymal Stem Cells Market size accounted for USD 3 billion in 2022 and is estimated to grow at 12.8% to reach USD 10.3 billion by 2032 due to the rising prevalence of chronic diseases such as cancer, autoimmune disease, diabetes coupled with increasing implication in the field of immune therapy, drug discovery and regenerative medicine.

To get key market trends

  Download Free Sample

For instance, in 2019, according to the World Health Organization (WHO), 18 million people globally were suffering from rheumatoid arthritis. Thus, rising prevalence of autoimmune disease is significantly propelling the demand for mesenchymal stem cells to develop effective therapies. Furthermore, increasing R&D activities by biopharmaceutical companies and growing application of mesenchymal stem cells in toxicology and safety testing.

Mesenchymal stem cells (MSCs) are a type of multipotent stem cells that can differentiate into various cell types like bone, cartilage, and fat within the body's mesodermal lineage. These cells are found in various tissues of the body, such as bone marrow, adipose tissue, umbilical cord among others that possess self-renewal capabilities, enabling them to multiply and generate more MSCs. These cells offer distinctive feature and their ability to modulate the immune system, make them appealing for therapeutic applications in areas such as tissue repair, regenerative medicine, and immune modulation.